Cargando…
Personalized Medicine and Cancer
Cancer is one of the leading causes of death in the United States, and more than 1.5 million new cases and more than 0.5 million deaths were reported during 2010 in the United States alone. Following completion of the sequencing of the human genome, substantial progress has been made in characterizi...
Autor principal: | Verma, Mukesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251363/ https://www.ncbi.nlm.nih.gov/pubmed/25562699 http://dx.doi.org/10.3390/jpm2010001 |
Ejemplares similares
-
Proteomics, Personalized Medicine and Cancer
por: Su, Miao, et al.
Publicado: (2021) -
Pancreatic Cancer Biomarkers and Their Implication in Cancer Diagnosis and Epidemiology
por: Verma, Mukesh
Publicado: (2010) -
Personalized medicine in colorectal cancer
por: Vaseghi Maghvan, Padina, et al.
Publicado: (2020) -
Personalized immunotherapy in cancer precision medicine
por: Kiyotani, Kazuma, et al.
Publicado: (2021) -
Ovarian Cancer Immunotherapy and Personalized Medicine
por: Morand, Susan, et al.
Publicado: (2021)